5don MSN
Pro-life organization calls on HHS and FDA to suspend abortion pill approval, tighten safety rules
Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...
North Korea launched multiple short-range ballistic missiles toward the sea between the Korean Peninsula and Japan on Tuesday ...
Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.
The Alcohol Alternative Industry Is Exploding. But Are These Products Really Safer? Experts Weigh in
From CBD to kratom to nootropics, the active ingredients at the center of this growing industry may lead to serious health ...
The families of two men killed in a U.S. missile strike have filed a wrongful death lawsuit, claiming the attack was unlawful. The case, involving Chad Joseph and Rishi Samaroo, challenges U.S.
Straight Arrow News (English) on MSN
Trump sends Homan to Minneapolis, Bovino exits; Millions dig out amid deep freeze
Watch now: Homan heads to Minneapolis today, replacing Bovino. Plus, millions of Americans dig out from under the snow amid a ...
He recently ran 500 miles from Colorado Springs to Moab while microdosing psilocybin and other psychedelics, to understand ...
The pharmaceutical company is running investigational new drug experiments, studies required by the FDA to demonstrate the ...
The first government-run marijuana retailer in Minnesota is set to open its doors next week, local officials say. After getting cleared to build the facility, the city of Anoka said it has completed ...
This AIRmail examines Jonas Vingegaard’s decision to target the Giro / Tour double, unresolved U.S. broadcast rights, Strava’s IPO, the escalating cost of watching professional sports and more ...
LGBTQ Nation on MSN
Gay men, ketamine and trauma. A therapy or a trap?
As ketamine’s reputation shifts from club drug to mental-health treatment, more gay and bisexual men are using it to quiet ...
LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results